Scientists at the Institute of Cancer Research and the Royal Marsden NHS Foundation Trust used a drug made from a genetically modified form of herpes simplex — the cold sore virus — to attack tumors in cancer patients' bodies, developing a cutting-edge form of cancer therapy in the process.
In a social media landscape shaped by hashtags, algorithms, and viral posts, nurse leaders must decide: Will they let the narrative spiral, or can they adapt and join the conversation?
...
